Vasopressin and normal saline in controlling blood loss during laparoscopic hysterectomy.

Vasopressin versus normal saline to control blood loss during laparoscopic hysterectomy: A Randomized control trial - nil

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059410

Enrollment

Registered

2023-11-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: randomized control trial: comparison of blood loss between test and control group Control Intervention1: Drug: vasopressin: To compare blood loss during laparoscopic hysterectomy using

Eligibility

Inclusion criteria

Inclusion criteria: -Patients with benign conditions with an indication for laparoscopic hysterectomy - Patients fit for general anesthesia

Exclusion criteria

Exclusion criteria: -Patients with Hb -Patients with any contraindication to vasopressin -Patients with bleeding disorders -Patients with gynecological malignancies -Patients unfit for general anesthesia

Design outcomes

Primary

Measure	Time frame
Blood loss will be compared between test group and control groupTimepoint: 6 months	—

Secondary

Measure	Time frame
less complications with vasopressin than normal salineTimepoint: 6 months	—

Countries

India

Contacts

Public ContactRavi Sah

ALL INDIA INSTITUTE OF MEDICAL SCIENCES

aamrity@gmail.com8171025511

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026